Human inborn errors of immunity associated with IRF4.

IRF4 cancer inborn errors of immunity interferon regulatory factor family primary antibody deficiency

Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2023
Historique:
received: 08 06 2023
accepted: 05 09 2023
medline: 1 11 2023
pubmed: 9 10 2023
entrez: 9 10 2023
Statut: epublish

Résumé

The transcription factor interferon regulatory factor 4 (IRF4) belongs to the IRF family and has several important functions for the adaptive immune response. Mutations affecting IRF family members IRF1, IRF3, IRF7, IRF8, or IRF9 have been described in patients presenting with inborn errors of immunity (IEI) highlighting the importance of these factors for the cellular host defense against mycobacterial and/or viral infections. IRF4 deficiency and haploinsufficiency have been associated with IEI. More recently, two novel IRF4 disease-causing mechanisms have been described due to the characterization of IEI patients presenting with cellular immunodeficiency associated with agammaglobulinemia. Here, we review the phenotypes and physiopathological mechanisms underlying IEI of IRF family members and, in particular, IRF4.

Identifiants

pubmed: 37809068
doi: 10.3389/fimmu.2023.1236889
pmc: PMC10556498
doi:

Substances chimiques

Interferon Regulatory Factors 0
interferon regulatory factor-4 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1236889

Informations de copyright

Copyright © 2023 Thouenon and Kracker.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Clin Immunol. 2020 Jan;40(1):24-64
pubmed: 31953710
Dig Dis Sci. 1981 Mar;26(3):247-52
pubmed: 6165533
Nat Immunol. 2003 Nov;4(11):1144-50
pubmed: 14556004
Biochimie. 2007 Jun-Jul;89(6-7):744-53
pubmed: 17399883
Cell. 1989 Aug 25;58(4):729-39
pubmed: 2475256
Sci Rep. 2017 Dec 12;7(1):17402
pubmed: 29234109
Immunity. 2017 Sep 19;47(3):481-497.e7
pubmed: 28930660
Mol Cell Biol. 2006 Nov;26(22):8303-15
pubmed: 16982701
Oncogene. 1991 Apr;6(4):533-42
pubmed: 1827665
Nat Genet. 1997 Oct;17(2):226-30
pubmed: 9326949
Aging (Albany NY). 2021 Apr 26;13(8):12086-12098
pubmed: 33902005
Proc Natl Acad Sci U S A. 2005 Nov 1;102(44):15989-94
pubmed: 16236719
Cell. 2013 Nov 21;155(5):1022-33
pubmed: 24267888
Nucleic Acids Res. 2021 Feb 26;49(4):2255-2265
pubmed: 33533913
Adv Exp Med Biol. 2013;783:45-80
pubmed: 23468103
Eur J Immunol. 2007 Feb;37(2):306-9
pubmed: 17273997
Cell Biosci. 2015 Apr 18;5:17
pubmed: 25960866
Nature. 1989 Jan 19;337(6204):270-2
pubmed: 2911367
J Biol Chem. 2015 Nov 13;290(46):27779-90
pubmed: 26405037
Science. 2020 Oct 23;370(6515):
pubmed: 32972995
Cell. 1988 Sep 9;54(6):903-13
pubmed: 3409321
Mol Cell Biol. 2002 Nov;22(21):7439-48
pubmed: 12370291
Eur J Immunol. 2019 Nov;49(11):2111-2114
pubmed: 31250433
Immunity. 2022 Nov 8;55(11):2044-2058.e5
pubmed: 36288724
N Engl J Med. 2011 Jul 14;365(2):127-38
pubmed: 21524210
Front Immunol. 2020 Mar 31;11:444
pubmed: 32296416
Cancer Cell. 2019 Apr 15;35(4):559-572.e7
pubmed: 30905761
EMBO J. 1999 Feb 15;18(4):977-91
pubmed: 10022840
Nat Commun. 2017 Aug 21;8(1):301
pubmed: 28824171
Cancer Res. 1996 Feb 1;56(3):612-5
pubmed: 8564980
Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3402-7
pubmed: 17360658
Nat Immunol. 2013 Nov;14(11):1155-65
pubmed: 24056747
Science. 1996 Dec 6;274(5293):1739-44
pubmed: 8939871
Proc Natl Acad Sci U S A. 2004 Aug 3;101(31):11416-21
pubmed: 15272082
Oncoimmunology. 2012 Nov 1;1(8):1376-1386
pubmed: 23243601
Nature. 2001 Sep 6;413(6851):78-83
pubmed: 11544529
Science. 1993 Feb 12;259(5097):968-71
pubmed: 8438156
J Exp Med. 2023 Jun 5;220(6):
pubmed: 36917008
J Exp Med. 2022 Jul 4;219(7):
pubmed: 35670811
J Immunol. 2000 Jul 1;165(1):271-9
pubmed: 10861061
Med Microbiol Immunol. 2019 Dec;208(6):869-876
pubmed: 31172279
J Allergy Clin Immunol. 2018 May;141(5):1924-1927.e18
pubmed: 29408330
Cell. 2023 Feb 2;186(3):621-645.e33
pubmed: 36736301
Nat Commun. 2020 Nov 13;11(1):5762
pubmed: 33188184
Science. 2015 Apr 24;348(6233):448-53
pubmed: 25814066
Cold Spring Harb Symp Quant Biol. 1999;64:465-72
pubmed: 11232323
Nat Immunol. 2006 Jan;7(1):40-8
pubmed: 16286919
Immunity. 2000 Oct;13(4):539-48
pubmed: 11070172
Front Immunol. 2019 May 24;10:1176
pubmed: 31178872
Blood. 2020 Jan 23;135(4):274-286
pubmed: 31738823
Annu Rev Immunol. 2008;26:535-84
pubmed: 18303999
Immunol Rev. 2012 May;247(1):73-92
pubmed: 22500833
Proc Natl Acad Sci U S A. 2021 Nov 9;118(45):
pubmed: 34702736
Immunity. 2013 May 23;38(5):918-29
pubmed: 23684984
Immunity. 2022 Dec 13;55(12):2369-2385.e10
pubmed: 36370712
J Allergy Clin Immunol. 2019 Jul;144(1):309-312.e10
pubmed: 30826365
Genome Biol. 2023 Jun 27;24(1):154
pubmed: 37370113
Nature. 2012 Oct 25;490(7421):543-6
pubmed: 22992523
J Exp Med. 2018 Feb 5;215(2):699-718
pubmed: 29339449
Immunity. 2006 Aug;25(2):225-36
pubmed: 16919487
Aging (Albany NY). 2020 Feb 10;12(3):2747-2763
pubmed: 32039830
FEBS Lett. 2002 Nov 6;531(2):348-53
pubmed: 12417340
Arch Pharm Res. 2016 Nov;39(11):1548-1555
pubmed: 27826752
Gastroenterology. 1996 Jan;110(1):52-7
pubmed: 8536888
Cell Rep. 2020 Dec 22;33(12):108517
pubmed: 33357426
N Engl J Med. 2007 Jan 4;356(1):55-66
pubmed: 17202456
Elife. 2018 Mar 14;7:
pubmed: 29537367
Gene. 1999 Sep 3;237(1):1-14
pubmed: 10524230
Nature. 2005 Apr 7;434(7034):772-7
pubmed: 15800576
J Clin Immunol. 2021 Jan;41(1):26-27
pubmed: 33392853
Nat Genet. 2015 Nov;47(11):1304-15
pubmed: 26437031
J Exp Med. 2018 Oct 1;215(10):2567-2585
pubmed: 30143481
J Exp Med. 2015 Aug 24;212(9):1371-9
pubmed: 26216125
Sci Immunol. 2023 Jan 20;8(79):eade7953
pubmed: 36662884
PLoS Genet. 2008 May 16;4(5):e1000074
pubmed: 18483556

Auteurs

Romane Thouenon (R)

Université Paris Cité, Paris, France.
Laboratory of Human Lymphohematopoiesis, Imagine Institute, INSERM UMR, Paris, France.

Sven Kracker (S)

Université Paris Cité, Paris, France.
Laboratory of Human Lymphohematopoiesis, Imagine Institute, INSERM UMR, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH